Eurofins Scientific SE: Transplant Genomics announces launch of Trugraf® Liver, the first and only non-invasive gene expression diagnostic test to optimise immunosuppression in liver transplant recipients
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide which is part of the Eurofins network of companies, is pleased to announce the commercial availability of TruGraf® Liver, a blood-based gene expression test that provides guidance for optimisation of immunosuppression therapy in liver transplant recipients. For liver transplant recipients, TruGraf
Eurofins Scientific SE: Transplant Genomics announces launch of Trugraf® Liver, the first and only non-invasive gene expression diagnostic test to optimise immunosuppression in liver transplant recipients
LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide which is part of the Eurofins network of companies, is pleased to announce the commercial availability of TruGraf® Liver, a blood-based gene expression test that provides guidance for optimisation of immunosuppression therapy in liver transplant recipients. For liver transplant recipients, TruGraf